纤维原蛋白超级家族蛋白质:肝脏疾病的关键调节者
Rong-Hui Qu1, Yi Rong1, Wen-Zhe Ni1
1College of Life Sciences, Shandong Agricultural University, Tai'an 271018, Shandong Province, China.
纤维原蛋白超级家族蛋白调节肝脏健康,提供保护,但也在过度活跃时驱动疾病. 针对这些蛋白质,如FGL1,显示出治疗肝脏疾病和癌症的前景.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肝脏疾病给全球健康带来了挑战.
- 纤维素 (FG) 超级蛋白家族 (FG,FGL1,FGL2) 影响肝脏再生,新陈代谢和癌症.
- 它们在肝脏疾病中的作用需要系统检查.
研究的目的:
- 审查FG超级家族蛋白质与主要肝脏疾病之间的病理生理联系.
- 阐明这些蛋白质在肝脏健康和疾病中的双重调节作用.
- 突出它们在治疗肝脏疾病方面的治疗潜力.
主要方法:
- 对现有文献进行系统审查.
- 分子机制的分析.
- 检查病理生理学相关性.
主要成果:
- FG超级家族蛋白质在再生和矩阵重塑中具有肝脏保护作用.
- 过度活化矛盾地促进炎症,代谢功能障碍和癌症进展.
- 详细介绍了肝炎,脂肪肝疾病和肝细胞癌中的特定作用.
结论:
- FG超级家族蛋白在肝脏病理生理学中表现出双重作用.
- 准FGL1/淋巴细胞激活基因3轴是一种新的免疫疗法策略.
- 这些蛋白质代表肝脏疾病和癌症的潜在治疗点.
更多相关视频
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Clot Retraction and Fibrinolysis
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Regulation of Angiogenesis and Blood Supply
